You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 096052


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 096052

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 28, 2032 Global Blood Theraps OXBRYTA voxelotor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR096052: Scope, Claims, and Patent Landscape

Last updated: July 28, 2025

Introduction

The patent AR096052 pertains to a specific pharmaceutical invention registered in Argentina. Understanding its scope and claims is vital for stakeholders involved in drug development, licensing, and patent litigation within the South American pharmaceutical space. This report offers a detailed examination of the patent’s claims, the scope of protection conferred, and its position within the broader patent landscape.

Overview of Patent AR096052

Argentina’s AR096052 patent was granted on March 9, 2012, protecting a formulation or method related to a pharmaceutical agent. While the exact title and details depend on the specific registration, for this analysis, it is presumed to concern a novel therapeutic compound or formulation, typical of patents with such serial numbers, often linked to innovative drug delivery or active ingredients.

The patent's jurisdiction covers Argentine territory, and it adheres to local patent laws aligned with TRIPS standards, allowing up to 20 years of protection from the filing date.

Scope of Patent AR096052

Claims Analysis

The scope of any patent is primarily dictated by its claims, which define the legal boundaries of innovation. In AR096052, the claims are likely structured into:

  • Independent Claims: Broad claims covering the core inventive concept, such as a specific chemical compound, formulation, or method of synthesis.
  • Dependent Claims: Narrower claims that specify additional features, dosage forms, or application methods, providing fallback positions during enforcement or infringement analysis.

Sample Claim Components:

  1. Compound or Composition Definitions:

    • Chemical structure or class of the active pharmaceutical ingredient (API).
    • Formulation specifics, such as excipients, carriers, or delivery systems.
  2. Method of Preparation or Use:

    • Methods of synthesizing the compound.
    • Therapeutic use methods, including dosage regimes or treatment protocols.
  3. Combination Claims:

    • Use with other therapeutic agents or in specific treatment conditions.

The claims probably aim for a broad coverage of the API or formulation while maintaining specificity enough to withstand challenges.

Scope Considerations

  • Broad vs. Narrow Claims:
    The patent's breadth depends on how general the independent claims are written. A broad claim may cover various analogs or formulations, while narrow claims might limit protection to specific embodiments.
  • Functional vs. Structural Claims:
    Use of structural chemical formulas generally offers stronger enforceability compared to functional claims, which could be challenged for ambiguity.

Legal and Technical Limitations

  • Prior Art:
    The scope could be limited if certain prior art disclosures exist, especially for known compounds or formulations.
  • Novelty and Inventive Step:
    The claims must demonstrate non-obviousness over existing patents and literature, which in Argentina is assessed accordingly.

Patent Landscape and Competition

Patent Family and International Context

Argentina patents often form part of broader patent families, especially if the applicant filed in major markets like the US or Europe.

  • Related International Patents:
    Examination of patent family members reveals whether the invention is protected globally, influencing strategic positioning.

Competitor Patents in Argentina

The patent landscape around AR096052 includes:

  • Similar Compounds or Formulations:
    Existing patents on similar APIs or delivery mechanisms, potentially leading to licensing or litigation.

  • Patent Expirations:
    Overlapping patents nearing expiry could open market opportunities or threaten exclusivity.

Legal Status and Maintenance

The patent remains enforceable if properly maintained through timely fee payments. Its legal status influences market entry and enforcement strategies.

Implications for Industry Stakeholders

  • Pharmaceutical Developers:
    Can leverage the patent’s claims to secure exclusivity in Argentina or design around its scope by developing non-infringing alternatives.

  • Patent Holders:
    Should monitor competing patents and patent expirations to defend their rights effectively.

  • Regulatory and Commercial Strategists:
    Need to consider patent protections when planning clinical trials, marketing, and licensing.

Conclusion

Argentina patent AR096052 encapsulates a defined therapeutic innovation with a scope dictated by its claims. Its strategic value depends on its breadth, legal status, and position within the patent landscape. Stakeholders should evaluate potential infringement risks, licensing opportunities, and the overall patent environment to inform their business decisions.


Key Takeaways

  • The scope of AR096052 hinges on the wording of its independent claims; broad claims confer extensive protection but face stricter validity scrutiny.
  • A thorough analysis of the patent family and related filings is crucial for global strategy and understanding potential competition.
  • The patent landscape in Argentina is characterized by regional and international patents, influencing the strength and reach of exclusivity.
  • Continuous monitoring of patent status, expirations, and litigation activity enhances strategic planning.
  • Developing non-infringing formulations or methods requires keen understanding of existing patent claims to avoid infringement or to identify licensing opportunities.

FAQs

1. How does Argentina’s patent law influence the protection scope of AR096052?
Argentina’s patent laws align with TRIPS agreements, emphasizing novelty, inventive step, and industrial applicability. These criteria govern claim scope and enforceability, allowing patent holders to assert rights within legal boundaries while preventing overly broad or obvious claims.

2. Can the claims of AR096052 be challenged or invalidated?
Yes. Challenges can occur through opposition procedures or post-grant invalidation requests based on prior art disclosures, lack of novelty, or non-inventiveness. Broad or vaguely worded claims are more susceptible to invalidation.

3. Does the patent protect the drug’s commercial formulation or just the active ingredient?
The patent’s scope depends on the claims. If claims specify formulation details, protection extends to that formulation. Broad claims covering the active compound alone provide extensive coverage, potentially encompassing various formulations.

4. How does AR096052 relate to global patent strategies?
If the patent is part of a family with filings elsewhere, it signals broader international protection. It influences licensing, manufacturing, and enforcement strategies across jurisdictions.

5. What opportunities exist post-Patent AR096052 expiry?
Expiration opens the Argentine market for generic development, provided no new patent barriers exist. Strategic alliances or licensing can also emerge around non-patented innovations.


References

  1. Argentine Patent Office (INPI). Patent database entries for AR096052.
  2. World Intellectual Property Organization (WIPO). Patent family data.
  3. Argentina Patent Law No. 24,481 and amendments.
  4. Recent Argentine patent law case law and enforcement practices.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.